Adding weekly GLP-1 to cognitive behavioral therapy further reduces h… | HappeningNow.news
Published Date: May 03, 2026

Health NIH

Adding weekly GLP-1 to cognitive behavioral therapy further reduces heavy drinking

Clinical trial suggests semaglutide may help patients with alcohol use disorder and obesity.

AI Summary POWERED BY HAPPENING NOW AI

Clinical trial suggests semaglutide may help patients with alcohol use disorder and obesity.

Read full article →

AI summaries can be wrong sometimes—always verify important details using the source link below.